1-4 of 4
Jesper Skov Neergaard
Close
Sort by
Journal Articles

Understanding Treatment Burden in Pediatric Hemophilia: Development of the Child Hemophilia Treatment Experience Measure (Child Hemo-TEM)

Meryl Brod, Anne Kirstine Busk, Jesper Skov Neergaard
Journal: Blood
Blood (2023) 142 (Supplement 1): 3755.
https://doi.org/10.1182/blood-2023-174495
Published: 2023
Journal Articles

Assessing Treatment Burden in Pediatric Hemophilia: Validation of the Observer-Reported Child Hemophilia Treatment Experience Measure (Child Hemo-TEM)

Meryl Brod, Donald M. Bushnell, Anne Kirstine Busk, Jesper Skov Neergaard
Journal: Blood
Blood (2023) 142 (Supplement 1): 2367.
https://doi.org/10.1182/blood-2023-172900
Published: 2023
Journal Articles

Treatment Burden and Patient Preference in Patients with Hemophilia A or B with Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

Kingsley Hampton, Paul Knoebl, Jan Odgaard-Jensen, Oleksandra Stasyshyn, Jay Jay Thaung Zaw, Jesper Skov Neergaard, Bulent Zulfikar
Journal: Blood
Blood (2022) 140 (Supplement 1): 5591–5592.
https://doi.org/10.1182/blood-2022-163468
Published: 2022
Journal Articles

Health-Related Quality of Life in Patients with Hemophilia A or B with Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

Amy D. Shapiro, Aby Abraham, Silvia Linari, Jesper Skov Neergaard, Jan Odgaard-Jensen, Jay Jay Thaung Zaw, Huyen Tran
Journal: Blood
Blood (2022) 140 (Supplement 1): 2732–2734.
https://doi.org/10.1182/blood-2022-166306
Published: 2022